selitzin

American Renal Associates Poised to Go Down in Flames

做空
selitzin 已更新   
NYSE:ARA   None
ARA very low market share in the dialysis space (3%), and facing competitive disadvantages compared to the bigger players. Also, California Assembly just passed dialysis legislation SB 1156 which caps commercial dialysis payments at lower Medicare rates. On its way to $150....
评论:
Change price Target to $15 from 150....
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。